HansBiomed Corporation (KOSDAQ:042520)
South Korea · Delayed Price · Currency is KRW 50,400
-100 (-0.20%)
At close: Feb 27, 2026
HansBiomed Cash Flow Statement
Financials in millions KRW. Fiscal year is October - September.
Millions KRW. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Net Income | -27,444 | -31,341 | -7,223 | -23,045 | 6,147 | -18,289 |
Depreciation & Amortization | 4,950 | 5,112 | 5,386 | 5,198 | 4,902 | 4,785 |
Loss (Gain) From Sale of Assets | -10.09 | -12.42 | 73.02 | 16.98 | -1.6 | -54.82 |
Asset Writedown & Restructuring Costs | - | - | -4.4 | 366.16 | - | - |
Loss (Gain) From Sale of Investments | 812.88 | 812.88 | 1,658 | - | - | - |
Loss (Gain) on Equity Investments | 572.39 | 557.18 | 2,235 | 1,857 | 2,644 | - |
Stock-Based Compensation | 3.61 | 21.09 | 42.57 | 2,447 | 59.76 | 226.06 |
Provision & Write-off of Bad Debts | 195.42 | 53.37 | 1,568 | -116.39 | 153.96 | 2,780 |
Other Operating Activities | 23,994 | 25,286 | 2,145 | 14,779 | -11,797 | -5,228 |
Change in Accounts Receivable | -12,721 | -7,281 | -2,215 | -3,621 | -748.02 | 694.62 |
Change in Inventory | 385.81 | -462.78 | -2,558 | -2,645 | -5,963 | 3,482 |
Change in Accounts Payable | 3,610 | 1,712 | 814.94 | 1,062 | -1,638 | -1,554 |
Change in Income Taxes | 56.44 | - | - | -124.27 | - | - |
Change in Other Net Operating Assets | -17,899 | 5,861 | -163.16 | 91.85 | 1,971 | -1,487 |
Operating Cash Flow | -23,494 | 318.34 | 1,759 | -3,733 | -4,270 | -14,645 |
Operating Cash Flow Growth | - | -81.90% | - | - | - | - |
Capital Expenditures | -2,349 | -1,862 | -2,594 | -1,937 | -3,986 | -4,891 |
Sale of Property, Plant & Equipment | 40.27 | 105.51 | 61.27 | 72.39 | 80.81 | 48.7 |
Sale (Purchase) of Intangibles | -57.18 | -57.18 | -234.71 | -135.76 | -147.84 | -87.04 |
Investment in Securities | -1,520 | -1,520 | -3,791 | 5,113 | 7,188 | -16,323 |
Other Investing Activities | 100.56 | 107.82 | -22.8 | 10.65 | -28.86 | 19.78 |
Investing Cash Flow | -7,301 | -5,237 | -6,595 | 3,320 | 3,167 | -21,190 |
Long-Term Debt Issued | - | 7,000 | 7,000 | - | 15,000 | 37,976 |
Total Debt Issued | 7,000 | 7,000 | 7,000 | - | 15,000 | 37,976 |
Long-Term Debt Repaid | - | -1,190 | -1,130 | -1,093 | -9,925 | -16,919 |
Net Debt Issued (Repaid) | 5,875 | 5,810 | 5,870 | -1,093 | 5,075 | 21,057 |
Issuance of Common Stock | 35,925 | - | - | - | - | 7,497 |
Repurchase of Common Stock | - | - | -5 | -788.29 | -4,553 | -20 |
Other Financing Activities | -54.07 | -0 | -0 | 1,053 | 864.28 | 1,204 |
Financing Cash Flow | 41,746 | 5,810 | 5,865 | -828.51 | 1,387 | 29,738 |
Foreign Exchange Rate Adjustments | -572.34 | -1.32 | 99 | -151.03 | 189.65 | 134.72 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -827.63 |
Net Cash Flow | 10,378 | 889.57 | 1,128 | -1,392 | 473.14 | -6,790 |
Free Cash Flow | -25,843 | -1,544 | -835.74 | -5,670 | -8,256 | -19,535 |
Free Cash Flow Margin | -25.80% | -1.72% | -1.03% | -7.27% | -11.09% | -33.06% |
Free Cash Flow Per Share | -1975.67 | -118.88 | -64.54 | -529.02 | -628.48 | -1951.22 |
Cash Interest Paid | 1,838 | 1,814 | 1,632 | 1,381 | 794.56 | 611.45 |
Cash Income Tax Paid | 936.13 | 804.46 | 327.7 | 214.65 | 243.11 | 1,505 |
Levered Free Cash Flow | -15,166 | 9,427 | -7,421 | 1,977 | -16,356 | -3,746 |
Unlevered Free Cash Flow | -14,024 | 10,571 | -6,311 | 5,429 | -12,429 | -1,560 |
Change in Working Capital | -26,568 | -170.85 | -4,121 | -5,237 | -6,378 | 1,135 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.